Long-Acting Small Molecule Drug Technology Platform

This technology platform employs biodegradable polymer materials and advanced manufacturing processes to encapsulate the active ingredients of medications within micron-sized spherical polymers, thus forming drug-polymer complexes. When introduced via subcutaneous or intramuscular injection into the human body, these complexes gradually release the medication by means of polymer degradation and diffusion. This controlled release mechanism leads to sustained effects that can span from days to months.

The advantages of extended-release formulations are rooted in their capability to alleviate the necessity for frequent dosing often associated with short-acting drugs, consequently enhancing patient's medication compliance and overall quality of life. Meantime, in terms of drug release kinetics, maintaining stable drug concentrations in the bloodstream is achievable, thereby minimizing the potential for adverse effects.

Our Distinctive Edge and Expertise

At UBI Pharma Inc., we've cultivated an extensive reservoir of formulation and process expertise within our laboratories. This foundation empowers us to develop products with dissolution profiles akin to reference drugs.

Additionally, our adeptness shines in our ability to finely calibrate process parameters and polymer chemical compositions with remarkable flexibility. This adaptability grants us the precision needed to orchestrate drug release cycles tailored precisely to the diverse demands of distinct medical indications.

We are well-equipped to assist clients in product development, formulation optimization, and process upscaling, ensuring that the final products meet the highest standards in terms of quality and efficacy.